Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon R Knight

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Clinical Transplantation|October 15, 2016
Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus?Simon R Knight, Samia Hussain
Current Opinion in Organ Transplantation|May 31, 2019
Noninvasive biomarkers in monitoring kidney allograft healthJohn M O'Callaghan, Simon R Knight
ANZ Journal of Surgery|October 10, 2013
Outcomes after pulmonary metastasectomy for colorectal cancerNisal K Perera, Simon R Knight
Transplantation|June 27, 2008
Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic reviewSimon R Knight, Peter J Morris
Neurosurgery Clinics of North America|November 18, 2008
Pancoast tumorsGavin A Davis, Simon R Knight
Transplantation|February 22, 2011
Steroid avoidance or withdrawal in renal transplantationSimon R Knight, Peter J Morris
Transplantation|January 12, 2010
Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysisSimon R Knight, Peter J Morris
Transplant International : Official Journal of the European Society for Organ Transplantation|May 13, 2024
Transplant Trial WatchSimon R Knight, John M O'Callaghan
Transplant International : Official Journal of the European Society for Organ Transplantation|February 23, 2024
Transplant Trial WatchSimon R Knight, John M O'Callaghan
Transplantation|June 26, 2007
The clinical benefits of cyclosporine C2-level monitoring: a systematic reviewSimon R Knight, Peter J Morris
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Clinical Transplantation|October 15, 2016
Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus?Simon R Knight, Samia Hussain
Current Opinion in Organ Transplantation|May 31, 2019
Noninvasive biomarkers in monitoring kidney allograft healthJohn M O'Callaghan, Simon R Knight
ANZ Journal of Surgery|October 10, 2013
Outcomes after pulmonary metastasectomy for colorectal cancerNisal K Perera, Simon R Knight
Transplantation|June 27, 2008
Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic reviewSimon R Knight, Peter J Morris
Neurosurgery Clinics of North America|November 18, 2008
Pancoast tumorsGavin A Davis, Simon R Knight
Transplantation|February 22, 2011
Steroid avoidance or withdrawal in renal transplantationSimon R Knight, Peter J Morris
Transplantation|January 12, 2010
Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysisSimon R Knight, Peter J Morris
Transplant International : Official Journal of the European Society for Organ Transplantation|May 13, 2024
Transplant Trial WatchSimon R Knight, John M O'Callaghan
Transplant International : Official Journal of the European Society for Organ Transplantation|February 23, 2024
Transplant Trial WatchSimon R Knight, John M O'Callaghan
Transplantation|June 26, 2007
The clinical benefits of cyclosporine C2-level monitoring: a systematic reviewSimon R Knight, Peter J Morris
Pageof 6